Mitra Pinasthika Mustika Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Mitra Pinasthika Mustika Tbk. trades at Rp1,005 (market cap 4.41T, 1.13M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B, 24.34M 24h volume). The key difference: Mitra Pinasthika Mustika Tbk. is far larger — about 9.4× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (24.34M versus 1.13M). Which is the better fit depends on your goals.
| MPMX | PRDL | |
|---|---|---|
Market Cap | 4.41T | 470.58B |
Volume | 1.13M | 24.34M |
Lot | 11.34K | 243.39K |
Turnover | 1.13B | 6.7B |
Average Price | 1,000.47 | 275.09 |
Value | 1.13B | 6.7B |
Indicative Equilibrium Price | 1,005 | 272 |
Indicative Equilibrium Volume | 20.4K | 1.14K |
Trailing returns across standard periods
Latest headlines on both assets
PT Mitra Pinasthika Mustika Tbk (the Company) was establised by deed of notary public Mrs. Rukmasanti Hardjasatya, S.H., Jakarta No. 2 dated November 2, 1987 and amended with deed No.6 dated 1 July 1988.
Read more on MPMX →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →